273 related articles for article (PubMed ID: 36262189)
21. Potential of Liposomes for Enhancement of Oral Drug Absorption.
Daeihamed M; Dadashzadeh S; Haeri A; Akhlaghi MF
Curr Drug Deliv; 2017; 14(2):289-303. PubMed ID: 26768542
[TBL] [Abstract][Full Text] [Related]
22. Chase Dosing of Lipid Formulations to Enhance Oral Bioavailability of Nilotinib in Rats.
Koehl NJ; Holm R; Kuentz M; Griffin BT
Pharm Res; 2020 Jun; 37(7):124. PubMed ID: 32524365
[TBL] [Abstract][Full Text] [Related]
23. Nanovesicles for Nanomedicine: Theory and Practices.
Wadhwa S; Garg V; Gulati M; Kapoor B; Singh SK; Mittal N
Methods Mol Biol; 2019; 2000():1-17. PubMed ID: 31148004
[TBL] [Abstract][Full Text] [Related]
24. Liquid Crystalline Phases for Enhancement of Oral Bioavailability.
Zhang X; Wu W
AAPS PharmSciTech; 2021 Feb; 22(3):81. PubMed ID: 33619612
[TBL] [Abstract][Full Text] [Related]
25. Creatinine-based non-phospholipid vesicular carrier for improved oral bioavailability of Azithromycin.
Ullah S; Shah MR; Shoaib M; Imran M; Shah SW; Ali I; Ahmed F
Drug Dev Ind Pharm; 2017 Jun; 43(6):1011-1022. PubMed ID: 28157445
[TBL] [Abstract][Full Text] [Related]
26. Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs.
Song S; Tian B; Chen F; Zhang W; Pan Y; Zhang Q; Yang X; Pan W
Drug Dev Ind Pharm; 2015 Jan; 41(1):51-62. PubMed ID: 24111828
[TBL] [Abstract][Full Text] [Related]
27. Improved Oral Bioavailability Using a Solid Self-Microemulsifying Drug Delivery System Containing a Multicomponent Mixture Extracted from Salvia miltiorrhiza.
Bi X; Liu X; Di L; Zu Q
Molecules; 2016 Apr; 21(4):456. PubMed ID: 27070565
[TBL] [Abstract][Full Text] [Related]
28. Enhanced oral bioavailability and sustained delivery of glimepiride via niosomal encapsulation: in-vitro characterization and in-vivo evaluation.
Mohsen AM; AbouSamra MM; ElShebiney SA
Drug Dev Ind Pharm; 2017 Aug; 43(8):1254-1264. PubMed ID: 28330377
[TBL] [Abstract][Full Text] [Related]
29. Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan.
Ahad A; Raish M; Al-Jenoobi FI; Al-Mohizea AM
Curr Drug Deliv; 2018 Feb; 15(2):260-266. PubMed ID: 28521674
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in liposome surface modification for oral drug delivery.
Nguyen TX; Huang L; Gauthier M; Yang G; Wang Q
Nanomedicine (Lond); 2016 May; 11(9):1169-85. PubMed ID: 27074098
[TBL] [Abstract][Full Text] [Related]
31. Improved oral bioavailability of breviscapine via a Pluronic P85-modified liposomal delivery system.
Zhou Y; Ning Q; Yu DN; Li WG; Deng J
J Pharm Pharmacol; 2014 Jul; 66(7):903-11. PubMed ID: 24697705
[TBL] [Abstract][Full Text] [Related]
32. Improved oral bioavailability of notoginsenoside R1 with sodium glycocholate-mediated liposomes: Preparation by supercritical fluid technology and evaluation in vitro and in vivo.
Fan Q; Zhang Y; Hou X; Li Z; Zhang K; Shao Q; Feng N
Int J Pharm; 2018 Dec; 552(1-2):360-370. PubMed ID: 30292894
[TBL] [Abstract][Full Text] [Related]
33. Maximizing the Oral Bioavailability of Poorly Water-Soluble Drugs Using Novel Oil-Like Materials in Lipid-Based Formulations.
Abbasi S; Higashino H; Sato Y; Minami K; Kataoka M; Yamashita S; Harashima H
Mol Pharm; 2021 Sep; 18(9):3281-3289. PubMed ID: 34351769
[TBL] [Abstract][Full Text] [Related]
34. Development and characterization of mixed niosomes for oral delivery using candesartan cilexetil as a model poorly water-soluble drug.
Sezgin-Bayindir Z; Antep MN; Yuksel N
AAPS PharmSciTech; 2015 Feb; 16(1):108-17. PubMed ID: 25204859
[TBL] [Abstract][Full Text] [Related]
35. Enhancing the Oral Absorption of Kinase Inhibitors Using Lipophilic Salts and Lipid-Based Formulations.
Williams HD; Ford L; Han S; Tangso KJ; Lim S; Shackleford DM; Vodak DT; Benameur H; Pouton CW; Scammells PJ; Porter CJH
Mol Pharm; 2018 Dec; 15(12):5678-5696. PubMed ID: 30376336
[TBL] [Abstract][Full Text] [Related]
36. Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines.
Aburahma MH
Drug Deliv; 2016 Jul; 23(6):1847-67. PubMed ID: 25390191
[TBL] [Abstract][Full Text] [Related]
37. Labrasol-Enriched Nanoliposomal Formulation: Novel Approach to Improve Oral Absorption of Water-Insoluble Drug, Carvedilol.
Ghassemi S; Haeri A; Shahhosseini S; Dadashzadeh S
AAPS PharmSciTech; 2018 Oct; 19(7):2961-2970. PubMed ID: 30030724
[TBL] [Abstract][Full Text] [Related]
38. Albumin-Encapsulated Liposomes: A Novel Drug Delivery Carrier With Hydrophobic Drugs Encapsulated in the Inner Aqueous Core.
Okamoto Y; Taguchi K; Yamasaki K; Sakuragi M; Kuroda S; Otagiri M
J Pharm Sci; 2018 Jan; 107(1):436-445. PubMed ID: 28826882
[TBL] [Abstract][Full Text] [Related]
39. Nanosized Liposomes Containing Bile Salt: A Vesicular Nanocarrier for Enhancing Oral Bioavailability of BCS Class III Drug.
Arafat M; Kirchhoefer C; Mikov M; Sarfraz M; Löbenberg R
J Pharm Pharm Sci; 2017; 20(0):305-318. PubMed ID: 28885915
[TBL] [Abstract][Full Text] [Related]
40. Lipid-based vehicle for oral drug delivery.
Stuchlík M; Zák S
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2001 Dec; 145(2):17-26. PubMed ID: 12426768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
